期刊文献+

喉癌患者血清肿瘤标志物CYFRA21-1、CA724、CA199、CEA及SCCAg的检测及诊断价值 被引量:3

Analyse the levels of CYFRA21-1、CA724、CA199、CEA and SCCAg in patients with laryngeal and diagnostic value
下载PDF
导出
摘要 目的探讨血清肿瘤标志物的检测对喉癌患者的诊疗价值。方法分析2010年1月至2014年1月接受手术治疗51例喉癌患者的临床资料,列为观察组;并纳入45例健康体检者作为对照组。观察比较两组患者血清肿瘤标志物细胞角蛋白19片段(CYFRA21-1)、糖类抗原72-4(CA72-4)、糖类抗原19-9(CA19-9)、癌胚抗原(CEA)及鳞状细胞癌相关抗原(SCCAg)水平,并比观察组手术前各肿瘤标志物水平。采用ROC曲线分析血清肿瘤标志物对喉癌的诊断价值。结果观察组患者血清CYFRA21-1、CA724、CA199、CEA及SCCAg均高于对照组(P<0.001)。观察组患者接受手术治疗后,其血清肿瘤标志物(CYFRA21-1、CA724、CA199、CEA及SCCAg)呈现显著下降趋势,较手术前比较差异具有统计学意义(P<0.001)。ROC曲线分析显示,当CYFRA21-1取截点值2.264 ng/ml时对喉癌的诊断敏感度为88.24%,特异度为93.33%,优于其它肿瘤标志物。结论血清肿瘤标志物CYFRA21-1、CA724、CA199、CEA及SCCAg对喉癌具有一定诊断价值,其中CYFRA21-1的诊断价值最高。 Objective Our study was aimed to analyze the levels of CYFRA21-1、CA724、CA199、CEA and SCCAg in patients with la-ryngeal and diagnostic value. Methods Clinical data of patients with laryngeal cancer received operative treatment at our hospital from 2010 to 2014 were analyzed as Group A,51 cases. Healthy controls were enrolled as Group B,45 cases. Serum tumor marker cytokeratin 19 fragment (CYFRA21-1),carbohydrate antigen 72 -4(CA72 -4),carbohydrate antigen 19 -9(CA19 -9),carcinoembryonic antigen(CEA)and squamous cell carcinoma associated antigen( SCCAg)level were observed and compared in the two groups. Tumor marker levels of the observation group was compared before and after surgery. ROC curve analysis was used to analyze the diagnostic value of serum tumor markers for laryngeal cancer. Results Group A had higher levels of CYFRA21-1,CA724,CA199,CEA and SCCAg than these of Group B,the difference were sta-tistically significant( P 〈0. 001). After surgery,serum tumor marker reduced significantly( P 〈0. 001). The ROC analysis showed CYFRA21-1 had a diagnostic sensitivity of 88. 24% in the diagnosis of laryngeal cancer,a diagnostic sensitivity of 93. 33% with a cut-off value of 2. 264 ng/ml. Conclusion Detection of serum CYFRA21 -1、CA724、CA199、CEA and SCCAg levels can be applied to early diagnosis of laryngeal cancer.
出处 《临床和实验医学杂志》 2015年第11期904-906,共3页 Journal of Clinical and Experimental Medicine
关键词 喉癌 CYFRA21—1 CA724 CA199 CEA SCCAG 诊断 Laryngeal cancer CYFRA21-1 CA724 CA199 CEA SCCAg Diagnosis
  • 相关文献

参考文献12

  • 1Oliveira JF, Branquinho FA, Monteiro AR, et al. Laryngeal chondro- sarcoma - - ten years of experience [ J ]. Braz J Otorhinolaryngol, 2014,80(4) :354 -358.
  • 2Markou K, Christoforidou A, Karasmanis I, et al. Laryngeal cancer: epidemiologieal data from Nuorthem Greece and review of the literature [J]. Hippokratia, 2013,17(4) :313 -318.
  • 3Haws L Jr, Haws BT. Aerodigestive cancers: laryngeal cancer[J]. FP Essent, 2014,424(9) :26 -31.
  • 4Fiorini FR, Deganello A, Larotonda G, et al. Tobacco exposure and complications in conservative laryngeal surgery [ J ]. Cancers ( Basel ) , 2014,6(3) :1727 - 1735.
  • 5Ampil F, Nathan CA, Lian T, et al. Postoperative management in la- ryngeal cancer with subglottic extension and histologically negative nodes: which patients need adjuvant radiotherapy[ J]. Ear Nose Throat J, 2014,93(8) :354-360.
  • 6程黎明,邓玲燕,李辉军,管青.血清肿瘤标志物检测在肺癌诊断与临床分期中的应用[J].华中科技大学学报(医学版),2010,39(3):402-407. 被引量:43
  • 7Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer[ J]. JAMA Otolaryngol Head Neck Surg, 2014,140 (9) : 855 - 60.
  • 8Hebel F, Mamsopoulos K, Bohr C. Assessing quality of life in patiems after partial laryngectomy[ J]. Hippokrafia, 2014,18(2) :156 -161.
  • 9Hanada S, Nishiyama N, Mizuguchi S, et al. Clinicopathological signif- icance of combined analysis of 9ytokeratinl9 expression and preoperative serum CYFRA21 - 1 levels in human lung squamous cell carcinoma [J]. Osaka City Med J, 2013,5tl) :35 -44.
  • 10佟威威,佟广辉,王婧,秦晓松,卢丽萍,刘勇.Cyfra21-1、NSE、SCCA和CRP在肺癌诊断中的应用[J].中国免疫学杂志,2015,31(3):396-400. 被引量:64

二级参考文献23

  • 1程玉萍,华川.C反应蛋白测定在肿瘤中的临床应用[J].华北国防医药,2005,17(3):202-203. 被引量:28
  • 2郝敏,王静芳.宫颈癌流行病学研究与调查[J].国外医学(妇幼保健分册),2005,16(6):404-406. 被引量:91
  • 3Takada M,Masuda N,Matsuura E,et al.Measurement of cyt-okeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay[J].Br J Cancer,1995,71(1):160-165.
  • 4Bergman B,Brezicka F T,Engstrom C P,et al.Clinical usefulness of serum assays of neuron-specific enolase,carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer[J].Eur J Cancer,1993,29A(2):198-202.
  • 5Moro D,Villemain D,Vuillez J P,et al.CEA,CYFRA21-1 and SCC in non-small cell lung cancer[J].Lung Cancer,1995,13(2):169-176.
  • 6Schneider J,Philipp M,Velcovsky H G,et al.Pro-gastrin-releasing peptide(ProGRP),neuron specific enolase(NSE),carcinoembryonic antigen(CEA)and cytokeratin 19-fragments(CYFRA 21-1)in patients with lung cancer in comparison to other lung diseases[J].Anticancer Res,2003,23(2A):885-893.
  • 7Graziano S L,Mazid R,Newman N,et al.The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer[J].J Clin Oncol,1989,7(10):1398-1406.
  • 8Wieskopf B,Demangeat C,Purohit A,et al.Cyfra 21-1 as a biologic marker of non-small cell lung cancer.Evaluation of sensitivity,specificity,and prognostic role[J].Chest,1995,108(1):163-169.
  • 9Broers J L,Ramaekers F C,Rot M K,et al.Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies[J].Cancer Res,1988,48(11):3221-3229.
  • 10Pastor A,Menendez R,Cremades M J,et al.Diagnostic value of SCC,CEA and CYFRA 21.1 in lung cancer:a Bayesian analysis[J].Eur Respir J,1997,10(3):603-609.

共引文献110

同被引文献22

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部